Released on: July 2, 2008, 7:23 am

Press Release Author: The Scott Partnership

Industry:

Press Release Summary: (Nottingham, UK and Cambridge, USA 2 July 2008). ClinPhone,
the world\'s largest Clinical Technology Organization (CTO) and Cytel Inc., leading
statistical experts in adaptive clinical trials, announced today a unique
partnership that unites Cytel\'s validated adaptive trial statistical and
computational expertise with ClinPhone\'s robust suite of clinical technologies and
operational know-how.

Press Release Body: ClinPhone and Cytel - A New Partnership Delivering Complete
Solutions for Adaptive Clinical Trials

(Nottingham, UK and Cambridge, USA 2 July 2008). ClinPhone, the world\'s largest
Clinical Technology Organization (CTO) and Cytel Inc., leading statistical experts
in adaptive clinical trials, announced today a unique partnership that unites
Cytel\'s validated adaptive trial statistical and computational expertise with
ClinPhone\'s robust suite of clinical technologies and operational know-how.

This new partnership offers sponsors the combined expertise of the two organizations
in successful design, planning and implementation of adaptive and other complex
study designs. ClinPhone-Cytel adaptive trial solutions are tailored to the
requirements and objectives of each individual clinical development program. This
integrated service provides all the essential components for adaptive trial planning
and implementation, including study design consulting, trial simulations, supplies
planning and management, clinical data collection, randomization, trial supply
management, data analysis and reporting.

Adaptive Clinical Trials (ACTs) refer to clinical studies that use accumulating
response data to optimize pre-determined aspects of the study design without
undermining the validity and integrity of the trial. By making mid-course
adjustments to the trial, adaptive trials increase the ability to answer the study\'s
key research objectives, and improve the likelihood of a successful outcome.
ClinPhone-Cytel solutions combine the innovative statistical techniques and trial
technology advances that make designing and conducting adaptive trials practical for
sponsor organizations of all sizes.

Irving Dark, Cytel\'s Vice President of Clinical Research Services explains, \"The
ClinPhone-Cytel collaboration provides sponsors with the full-service offering
needed for successful Adaptive Clinical Trials. This partnership underscores our
commitment to be the leader in innovative trial design and implementation services.\"

Dr. Bill Byrom, Vice President, Product Strategy and Marketing of ClinPhone
comments, \"Technology plays a central role in delivering these types of studies, and
Cytel and ClinPhone together are leading the way in offering integrated services
that provide a comprehensive solution for the sponsor wishing to benefit from the
power of adaptive trials.\"

To learn more about ClinPhone\'s clinical trial technology solutions, please visit
www.clinphone.com, or alternatively e-mail info@clinphone.com.

To learn more about Cytel Inc, please visit www.cytel.com, or alternatively e-mail
info@cytel.com.

About ClinPhone
ClinPhone plc is the world\'s largest Clinical Technology Organization (CTO) with an
unrivaled track record of innovation in the development of clinical trial
technology. Headquartered in Nottingham UK with offices around the world, ClinPhone
works with leading global biotechnology organizations, pharmaceutical companies and
Contract Research Organizations (CROs).

ClinPhone is the largest and most accomplished CTO with experience in over 2,000
clinical trials spanning 88 countries and 71 languages. The Company\'s experience
includes Phase I to Phase IV studies, ranging from single center studies with 20
patients to \"mega trials\" with over 40,000 patients.

ClinPhone\'s product portfolio, consisting of software and services, is backed by
continuous research and investment in the latest technologies, coupled with
extensive in-depth clinical industry experience. Its industry-leading software
solutions include electronic data capture (EDC) and clinical trial management
systems (CTMS), which can be licensed or implemented as hosted solutions. Delivered
via its renowned Interactive Voice Response (IVR) and Interactive Web Response (IWR)
platform, ClinPhone offers randomization, trial supply management, trial supply
simulation, electronic patient reported outcomes (ePRO), and patient recruitment
solutions.

ClinPhone\'s products can integrate, taking the pain out of juggling and managing
multiple sources of disparate information. This approach provides more control over
data, improves data integrity and streamlines the data validation process.

About Cytel
Cytel pioneered the statistical science and computational technology of adaptive
clinical trials. Benefiting both sponsors and patients, Cytel has designed more
validated adaptive trials than anyone else.

Biopharmaceutical and device companies of all sizes turn to the clinical study
planning, simulation and implementation experience of Cytel. Cytel experts have
trained thousands of health sciences industry biostatisticians, clinicians, and
regulatory staff in the latest trial design techniques.

Cytel\'s Pharmaceutical Research Services place this clinical study innovation
experience at the disposal of your research and development programs. From trial
simulation and process development to independent data assessment and regulatory
review, Cytel stands with you every step of the way.

For further press information contact: Fiona Robinson, The Scott Partnership, 1
Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom Tel: + 44
1477 539539. Fax: +44 1477 539540 E:clinphone@scottpr.com


Web Site: http://

Contact Details: Contact Information:
Charlotte Culley/Fiona Robinson
The Scott Partnership
Phone: +44 (0) 1477 539539
E-mail: clinphone@scottpr.com

Kathleen Pomykola
ClinPhone plc
Phone: +1 609 524 4242
E-mail: kpomykol@clinphone.com

Michael Weitz
Cytel Inc
Phone: +1 617 661 2011
E-mail: mike@cytel.co